<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01444313</url>
  </required_header>
  <id_info>
    <org_study_id>CR-201009</org_study_id>
    <nct_id>NCT01444313</nct_id>
  </id_info>
  <brief_title>Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses</brief_title>
  <official_title>Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the short-term protective effect of Ultra-Violet
      filtering contact lenses on macular pigment ocular density.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Macular Pigment Optical Density at 9 months</measure>
    <time_frame>baseline to 9 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Macular Pigment Optical Density at 15 months</measure>
    <time_frame>baseline to 15 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Macular Pigment Optical Density at 3 months</measure>
    <time_frame>baseline to 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Macular Pigment Optical Density at 6 months</measure>
    <time_frame>baseline to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Macular Pigment Optical Density at 12 months</measure>
    <time_frame>baseline to 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>nelfilcon A OD / narafilcon A OS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Soft contact lens without UV protection worn on the right eye (OD) and soft contact lens with UV protection worn on the left eye (OS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>narafilcon A OD / nelfilcon A OS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Soft contact lens with UV protection worn on the right eye (OD) and soft contact lens without UV protection worn on the left eye (OS).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>narafilcon A contact lens</intervention_name>
    <description>Soft contact lenses with UV protection</description>
    <arm_group_label>nelfilcon A OD / narafilcon A OS</arm_group_label>
    <arm_group_label>narafilcon A OD / nelfilcon A OS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A soft contact lenses</intervention_name>
    <description>Soft contact lenses without UV protection</description>
    <arm_group_label>nelfilcon A OD / narafilcon A OS</arm_group_label>
    <arm_group_label>narafilcon A OD / nelfilcon A OS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is an adapted soft contact lens wearer

          -  The subject's spherical error equivalent (Best Sphere corrected for back vertex
             distance) must be from -0.50 diopters (D) to -6.00D or from +0.50D to +4.00D in each
             eye

          -  The subject must have a refractive astigmatism in each eye of -0.75D or less

          -  The subject must have a best corrected visual acuity of 6/9 or better in each eye.

          -  The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol

          -  The subject must read and sign the statement of informed consent

          -  The subject must be at least 18 years of age

        Exclusion Criteria:

          -  Systemic or ocular allergies which might interfere with contact lens wear

          -  Systemic disease which might interfere with contact lens wear

          -  Ocular disease which might interfere with contact lens wear

          -  Grade 3 or 4 Slit Lamp Findings

          -  Greater than 0.1 difference in macular pigment optical density (MPOD) findings between
             right and left eye at baseline visit

          -  On changing stable medication or taking any medication known to affect tear film

          -  Active ocular surface pathology

          -  Use ocular medication

          -  Had had any anterior ocular surgery or other ocular surgery or injury within 8 weeks
             immediately prior to enrollment for this study

          -  Significant ocular tissue anomaly

          -  Presence of two or more corneal scars in either eye

          -  Pregnancy or lactation, or intends to become pregnant during the time period of the
             study

          -  Any medical condition that may be prejudicial to the study

          -  Diabetes

          -  Infectious diseases (e.g. Hepatitis, tuberculosis)

          -  Contagious immunosuppressive diseases (e.g. HIV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B4 7ET</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2011</study_first_submitted>
  <study_first_submitted_qc>September 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2011</study_first_posted>
  <last_update_submitted>October 28, 2014</last_update_submitted>
  <last_update_submitted_qc>October 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

